Technological and clinical validation of the monitoring system of patients undergoing cancer treatment

• Grant number: 22/13644-2
• Support Opportunities: Research Grants - Innovative Research in Small Business - PIPE
• Start date: July 01, 2023
• End date: September 30, 2024
• Field of knowledge: Health Sciences - Medicine - Medical Clinics
• Agreement: SEBRAE-SP
• Principal Investigator: Joel de Oliveira Junior
• Grantee: Joel de Oliveira Junior
• Company: Luckie Tech Serviços e Tecnologias para Saúde Ltda
• CNAE: Atividades de apoio à gestão de saúde ; Atividades de atenção à saúde humana não especificadas anteriormente ; Atividades de fornecimento de infra-estrutura de apoio e assistência a paciente no domicílio
• City: São José dos Campos
• Associated researchers: Guilherme Hernandes Garcia Sanchez

Abstract

Luckie Tech was created after the founder lost a child to cancer and has the objective of decreasing the mortality rate of patients undergoing cancer treatment, we do this through a technological solution focused on monitoring the vital signs of patients undergoing cancer treatment. These patients are in a state called neutropenic which boils down to having their immune system suppressed, leaving them vulnerable to any opportune illnesses. The developed system has several technological aspects for monitoring, starting with the wearable device that is attached to the patient in their axillary region and sends the signals to a cloud architecture that sends them to the applications of those responsible for the patient (family) and for the medical staff (doctors and nurses) and also for a screen (dashboard) in the hospital which, in addition to the vital signs, shows the patient's location. We had the opportunity to have partnerships with several companies in Brazil, including Embraer, Compass Uol, Proa.AI, Johnson&Johnson, Skapa, Volvo, among others, so that the technology was functional and ready for a technological validation of this size. The technological validation that is being proposed will be carried out in stages, 60 patients will be monitored, including at least 28 childhood cancer patients (0-19 years) and other adults. Family, doctors and nurses training on the dedicated mobile apps. Technical and technological verification of vital signs of device prototypes. Our partner (Harena) is the company responsible for the innovation area of the largest cancer treatment hospital in South America, Hospital de Amor, in Barretos, Hospital de Amor, exists for 50 years, today with a built area of 70 thousand m² with eight service units that include a research institute, a children's hospital, it is considered the most advanced oncological hospital in Brazil with 100% service via SUS (Unico Health System)3000 patients are served a day by 250 doctors and 2500 employees and branches are opening in other states such as Pernambuco and Amazônia. International partnerships stand out and the last one is the Hospital's partnership with St Jude Children Hospital, the biggest reference in childhood cancer on the planet. All this shows that the partner we had the opportunity to work with is one of the best in the world to carry out this Technological Validation, they met us at an event for startups and invited us to have a project so that we could validate the proposed technology, it will be of importance huge for Luckie Tech, and for the Hospital that will validate the technology we have developed in its unit. We will have 24-hour technical follow-up of patients being monitored. Reports of occurrences, problems and proposed solutions at each validation stage. As it is a technological validation, it is possible that one of the by-products is the need for clinical validation of the process in the future, and in the future this clinical validation may be added to the certification process of the regulatory agency Anvisa to serve all hospitals focused on cancer from the country. This innovation in the way of monitoring patients could save the lives of thousands of patients, improve the quality of life during treatment and reduce treatment costs. (AU)